These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1900236)

  • 1. Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
    Krishnan S; Kolbe HV; Lepage P; Faure T; Sauerwald R; de la Salle H; Muller C; Bihoreau N; Paolantonacci P; Roitsch C
    Eur J Biochem; 1991 Feb; 195(3):637-44. PubMed ID: 1900236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.
    Bihoreau N; Paolantonacci P; Bardelle C; Fontaine-Aupart MP; Krishnan S; Yon J; Romet-Lemonne JL
    Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):23-31. PubMed ID: 1906711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
    Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a recombinant antihaemophilia-A factor (factor VIII-delta II) by matrix-assisted laser desorption/ionization mass spectrometry.
    Bihoreau N; Veillon JF; Ramon C; Scohyers JM; Schmitter JM
    Rapid Commun Mass Spectrom; 1995; 9(15):1584-8. PubMed ID: 8652881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
    Pittman DD; Millenson M; Marquette K; Bauer K; Kaufman RJ
    Blood; 1992 Jan; 79(2):389-97. PubMed ID: 1730084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
    Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.
    Mertens K; Donath MJ; van Leen RW; de Keyzer-Nellen MJ; Verbeet MP; Klaasse Bos JM; Leyte A; van Mourik JA
    Br J Haematol; 1993 Sep; 85(1):133-42. PubMed ID: 8251380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
    Schmidbauer S; Witzel R; Robbel L; Sebastian P; Grammel N; Metzner HJ; Schulte S
    Thromb Res; 2015 Aug; 136(2):388-95. PubMed ID: 26037285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
    Newell JL; Fay PJ
    J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
    Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
    Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.
    Pittman DD; Wang JH; Kaufman RJ
    Biochemistry; 1992 Apr; 31(13):3315-25. PubMed ID: 1554716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.
    Andersson LO; Forsman N; Huang K; Larsen K; Lundin A; Pavlu B; Sandberg H; Sewerin K; Smart J
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2979-83. PubMed ID: 3085106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL; Morrissey JH; Neuenschwander PF
    Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
    Lind P; Larsson K; Spira J; Sydow-Bäckman M; Almstedt A; Gray E; Sandberg H
    Eur J Biochem; 1995 Aug; 232(1):19-27. PubMed ID: 7556150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin.
    Chong YH; Jung JM; Choi W; Park CW; Choi KS; Suh YH
    Life Sci; 1994; 54(17):1259-68. PubMed ID: 8164508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dysfunctional factor VIII molecules.
    Hoyer LW
    Methods Enzymol; 1993; 222():169-76. PubMed ID: 8412792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a new recombinant factor VIII (N8).
    Thim L; Vandahl B; Karlsson J; Klausen NK; Pedersen J; Krogh TN; Kjalke M; Petersen JM; Johnsen LB; Bolt G; Nørby PL; Steenstrup TD
    Haemophilia; 2010 Mar; 16(2):349-59. PubMed ID: 19906157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).
    Arai M; Inaba H; Higuchi M; Antonarakis SE; Kazazian HH; Fujimaki M; Hoyer LW
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4277-81. PubMed ID: 2498882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.